In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex

Thrombosis and Haemostasis

Volumn 94, Issue 2, 2005, Pages 366-372

  Du, Ying Jun ^a   Klement, Petr ^a   Berry, Leslie R ^a   Tressel, Paul ^a   Chan, Anthony K C ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulant; ATH; Modified catheters; Polyurethane; Surface grafting

Indexed keywords

ANTITHROMBIN; ETHYLENE OXIDE; FIBRIN; FIBRINOGEN; HEPARIN; IODINE 125; POLYURETHAN; PROTEINASE;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; CATHETER; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; HYDROPHILICITY; IN VIVO STUDY; INSTRUMENT STERILIZATION; ISOTOPE LABELING; JUGULAR VEIN; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; RABBIT; RISK ASSESSMENT; SURFACE TENSION; THROMBOGENICITY; TREATMENT OUTCOME; VASCULAR PATENCY; VEIN THROMBOSIS;

ANIMALS; ANTICOAGULANTS; ANTITHROMBINS; BLOOD COAGULATION; CATHETERIZATION; COATED MATERIALS, BIOCOMPATIBLE; ETHYLENE OXIDE; FIBRIN; FIBRINOGEN; HEPARIN; HUMANS; MALE; MATERIALS TESTING; OXYGEN; POLYETHYLENE GLYCOLS; POLYURETHANES; RABBITS; SURFACE PROPERTIES; THROMBOSIS;

EID: 23744457851     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-09-0581     Document Type: Article

References (17)

1. Andrew M, Marzinotto V, Pencharz P et al. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr 1995; 126: 358-63.
2. Joffe HV, Goldhaber SZ. Upper-extremity deep vein thrombosis. Circulation 2002; 106: 1874-80.
3. Randolph AG, Cook DJ, Gonzales CA et al. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized control trials. Chest 1998; 113: 165-71.
4. Monreal M, Alastrue A, Rull M et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices-prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 251-3.
5. Spijker HT, Graaff R, Boonstra P W et al. On the influence of flow conditions and wettability on blood material interactions. Biomaterials 2003; 24: 4717-27.
6. Chan A, Berry L, Mitchell L et al. Evaluation of antithrombin-heparin covalent complex coated endoluminal grafts in rabbits. Transactions Soc Biomat 1999; 22: 102.
7. Chan AKC, Berry L, Andrew M, Klement P. Antithrombin-heparin covalent complex: a novel approach for improving thromboresistance of cardiovascular devices. International Biomaterials Congress 2000.
8. Klement P, Du YJ, Berry L et al. Blood-compatible biomaterials by surface coating with a novel antithrombin-heparin covalent complex. Biomaterials 2002; 23: 527-35.
9. Chan A, Berry L, Klement P et al. A novel antithrombin-heparin covalent complex: antithrombotic and bleeding studies in rabbits. Blood Coagul Fibrinolysis 1998; 9:587-95.
10. Klement P, Liao P, Bajzar L. A novel approach to arterial thrombolysis. Blood 1999; 94: 2735-43.
11. Klement P, Liao P, Hirsh J et al. Hirudin causes more bleeding than heparin in a rabbit ear bleeding model. J Lab Clin Med 1998; 132: 181-5.
12. Green D, Klement P, Liao P et al. Interaction of low molecular weight heparin with ketorolac. J Lab Clin Med 1996; 127:583-7.
13. Chan A, Berry L, O'Brodovich H et al. Covalent antithrombin-heparin complexes with high anticoagulant activity. Intravenous, subcutaneous, and intratracheal administration. J Biol Chem 1997; 272: 22111-7.
14. Paredes N, Wang A, Berry L et al. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex. J Biol Chem 2003; 278: 23398-409.
15. Berry L, Andrew M, Chan A. Antithrombin-heparin complexes. In: Dumitriu S, editor. Polymeric Biomaterials. Part II: Medical and Pharmaceutical Applications of Polymers. New York: Marcel Dekker Inc., 2001: 669-702.
16. Berry L, Stafford A, Fredenburgh J et al. Investigation of the anticoagulant mechanisms of a covalent antithrombin-heparin complex. J Biol Chem 1998; 273: 34730-6.
17. Chan AKC, Paredes N, Thong B et al. Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin. Thromb Haemost 2004; 91: 1009-18.